Global Klebsiella Pneumoniae Infection Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Klebsiella Pneumoniae Infection Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Klebsiella Pneumoniae Infection Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Klebsiella Pneumoniae Infection Drug by Country/Region, 2017, 2022 & 2028

2.2 Klebsiella Pneumoniae Infection Drug Segment by Type

2.2.1 ATI-1503

2.2.2 CA-824

2.2.3 CC-1807

2.2.4 Cefiderocol

2.2.5 Debio-1454

2.2.6 EBX-004

2.2.7 Others

2.3 Klebsiella Pneumoniae Infection Drug Sales by Type

2.3.1 Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Klebsiella Pneumoniae Infection Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Klebsiella Pneumoniae Infection Drug Sale Price by Type (2017-2022)

2.4 Klebsiella Pneumoniae Infection Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Klebsiella Pneumoniae Infection Drug Sales by Application

2.5.1 Global Klebsiella Pneumoniae Infection Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Klebsiella Pneumoniae Infection Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Klebsiella Pneumoniae Infection Drug Sale Price by Application (2017-2022)

3 Global Klebsiella Pneumoniae Infection Drug by Company

3.1 Global Klebsiella Pneumoniae Infection Drug Breakdown Data by Company

3.1.1 Global Klebsiella Pneumoniae Infection Drug Annual Sales by Company (2020-2022)

3.1.2 Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Company (2020-2022)

3.2 Global Klebsiella Pneumoniae Infection Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Klebsiella Pneumoniae Infection Drug Revenue by Company (2020-2022)

3.2.2 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company (2020-2022)

3.3 Global Klebsiella Pneumoniae Infection Drug Sale Price by Company

3.4 Key Manufacturers Klebsiella Pneumoniae Infection Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Klebsiella Pneumoniae Infection Drug Product Location Distribution

3.4.2 Players Klebsiella Pneumoniae Infection Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Klebsiella Pneumoniae Infection Drug by Geographic Region

4.1 World Historic Klebsiella Pneumoniae Infection Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Klebsiella Pneumoniae Infection Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Klebsiella Pneumoniae Infection Drug Annual Revenue by Geographic Region

4.2 World Historic Klebsiella Pneumoniae Infection Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Klebsiella Pneumoniae Infection Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Klebsiella Pneumoniae Infection Drug Annual Revenue by Country/Region

4.3 Americas Klebsiella Pneumoniae Infection Drug Sales Growth

4.4 APAC Klebsiella Pneumoniae Infection Drug Sales Growth

4.5 Europe Klebsiella Pneumoniae Infection Drug Sales Growth

4.6 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Growth

5 Americas

5.1 Americas Klebsiella Pneumoniae Infection Drug Sales by Country

5.1.1 Americas Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022)

5.1.2 Americas Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022)

5.2 Americas Klebsiella Pneumoniae Infection Drug Sales by Type

5.3 Americas Klebsiella Pneumoniae Infection Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Klebsiella Pneumoniae Infection Drug Sales by Region

6.1.1 APAC Klebsiella Pneumoniae Infection Drug Sales by Region (2017-2022)

6.1.2 APAC Klebsiella Pneumoniae Infection Drug Revenue by Region (2017-2022)

6.2 APAC Klebsiella Pneumoniae Infection Drug Sales by Type

6.3 APAC Klebsiella Pneumoniae Infection Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Klebsiella Pneumoniae Infection Drug by Country

7.1.1 Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022)

7.1.2 Europe Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022)

7.2 Europe Klebsiella Pneumoniae Infection Drug Sales by Type

7.3 Europe Klebsiella Pneumoniae Infection Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Klebsiella Pneumoniae Infection Drug by Country

8.1.1 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Type

8.3 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Klebsiella Pneumoniae Infection Drug

10.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug

10.4 Industry Chain Structure of Klebsiella Pneumoniae Infection Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Klebsiella Pneumoniae Infection Drug Distributors

11.3 Klebsiella Pneumoniae Infection Drug Customer

12 World Forecast Review for Klebsiella Pneumoniae Infection Drug by Geographic Region

12.1 Global Klebsiella Pneumoniae Infection Drug Market Size Forecast by Region

12.1.1 Global Klebsiella Pneumoniae Infection Drug Forecast by Region (2023-2028)

12.1.2 Global Klebsiella Pneumoniae Infection Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Klebsiella Pneumoniae Infection Drug Forecast by Type

12.7 Global Klebsiella Pneumoniae Infection Drug Forecast by Application

13 Key Players Analysis

13.1 Acies Bio doo

13.1.1 Acies Bio doo Company Information

13.1.2 Acies Bio doo Klebsiella Pneumoniae Infection Drug Product Offered

13.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Acies Bio doo Main Business Overview

13.1.5 Acies Bio doo Latest Developments

13.2 Appili Therapeutics

13.2.1 Appili Therapeutics Company Information

13.2.2 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product Offered

13.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Appili Therapeutics Main Business Overview

13.2.5 Appili Therapeutics Latest Developments

13.3 Debiopharm International SA

13.3.1 Debiopharm International SA Company Information

13.3.2 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product Offered

13.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Debiopharm International SA Main Business Overview

13.3.5 Debiopharm International SA Latest Developments

13.4 Evaxion Biotech ApS

13.4.1 Evaxion Biotech ApS Company Information

13.4.2 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product Offered

13.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Evaxion Biotech ApS Main Business Overview

13.4.5 Evaxion Biotech ApS Latest Developments

13.5 F. Hoffmann-La Roche Ltd

13.5.1 F. Hoffmann-La Roche Ltd Company Information

13.5.2 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product Offered

13.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 F. Hoffmann-La Roche Ltd Main Business Overview

13.5.5 F. Hoffmann-La Roche Ltd Latest Developments

13.6 FOB Synthesis Inc

13.6.1 FOB Synthesis Inc Company Information

13.6.2 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product Offered

13.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 FOB Synthesis Inc Main Business Overview

13.6.5 FOB Synthesis Inc Latest Developments

13.7 ImmunoClin Corp

13.7.1 ImmunoClin Corp Company Information

13.7.2 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product Offered

13.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 ImmunoClin Corp Main Business Overview

13.7.5 ImmunoClin Corp Latest Developments

13.8 Innovation Pharmaceuticals Inc

13.8.1 Innovation Pharmaceuticals Inc Company Information

13.8.2 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offered

13.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Innovation Pharmaceuticals Inc Main Business Overview

13.8.5 Innovation Pharmaceuticals Inc Latest Developments

13.9 Kyorin Pharmaceutical Co Ltd

13.9.1 Kyorin Pharmaceutical Co Ltd Company Information

13.9.2 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product Offered

13.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Kyorin Pharmaceutical Co Ltd Main Business Overview

13.9.5 Kyorin Pharmaceutical Co Ltd Latest Developments

13.10 Melinta Therapeutics Inc

13.10.1 Melinta Therapeutics Inc Company Information

13.10.2 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offered

13.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Melinta Therapeutics Inc Main Business Overview

13.10.5 Melinta Therapeutics Inc Latest Developments

13.11 Nosopharm SAS

13.11.1 Nosopharm SAS Company Information

13.11.2 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product Offered

13.11.3 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Nosopharm SAS Main Business Overview

13.11.5 Nosopharm SAS Latest Developments

13.12 Peptilogics Inc

13.12.1 Peptilogics Inc Company Information

13.12.2 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product Offered

13.12.3 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Peptilogics Inc Main Business Overview

13.12.5 Peptilogics Inc Latest Developments

13.13 Pfizer Inc

13.13.1 Pfizer Inc Company Information

13.13.2 Pfizer Inc Klebsiella Pneumoniae Infection Drug Product Offered

13.13.3 Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Pfizer Inc Main Business Overview

13.13.5 Pfizer Inc Latest Developments

13.14 Phico Therapeutics Ltd

13.14.1 Phico Therapeutics Ltd Company Information

13.14.2 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product Offered

13.14.3 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Phico Therapeutics Ltd Main Business Overview

13.14.5 Phico Therapeutics Ltd Latest Developments

13.15 Sarepta Therapeutics Inc

13.15.1 Sarepta Therapeutics Inc Company Information

13.15.2 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offered

13.15.3 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Sarepta Therapeutics Inc Main Business Overview

13.15.5 Sarepta Therapeutics Inc Latest Developments

13.16 Shionogi & Co Ltd

13.16.1 Shionogi & Co Ltd Company Information

13.16.2 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product Offered

13.16.3 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Shionogi & Co Ltd Main Business Overview

13.16.5 Shionogi & Co Ltd Latest Developments

13.17 Syntiron LLC

13.17.1 Syntiron LLC Company Information

13.17.2 Syntiron LLC Klebsiella Pneumoniae Infection Drug Product Offered

13.17.3 Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Syntiron LLC Main Business Overview

13.17.5 Syntiron LLC Latest Developments

13.18 Tetraphase Pharmaceuticals Inc

13.18.1 Tetraphase Pharmaceuticals Inc Company Information

13.18.2 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offered

13.18.3 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Tetraphase Pharmaceuticals Inc Main Business Overview

13.18.5 Tetraphase Pharmaceuticals Inc Latest Developments

14 Research Findings and Conclusion

Table 1. Klebsiella Pneumoniae Infection Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Klebsiella Pneumoniae Infection Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of ATI-1503

Table 4. Major Players of CA-824

Table 5. Major Players of CC-1807

Table 6. Major Players of Cefiderocol

Table 7. Major Players of Debio-1454

Table 8. Major Players of EBX-004

Table 9. Major Players of Others

Table 10. Global Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)

Table 11. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)

Table 12. Global Klebsiella Pneumoniae Infection Drug Revenue by Type (2017-2022) & ($ million)

Table 13. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Type (2017-2022)

Table 14. Global Klebsiella Pneumoniae Infection Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 15. Global Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)

Table 16. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)

Table 17. Global Klebsiella Pneumoniae Infection Drug Revenue by Application (2017-2022)

Table 18. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Application (2017-2022)

Table 19. Global Klebsiella Pneumoniae Infection Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 20. Global Klebsiella Pneumoniae Infection Drug Sales by Company (2020-2022) & (K Pcs)

Table 21. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Company (2020-2022)

Table 22. Global Klebsiella Pneumoniae Infection Drug Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company (2020-2022)

Table 24. Global Klebsiella Pneumoniae Infection Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 25. Key Manufacturers Klebsiella Pneumoniae Infection Drug Producing Area Distribution and Sales Area

Table 26. Players Klebsiella Pneumoniae Infection Drug Products Offered

Table 27. Klebsiella Pneumoniae Infection Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Klebsiella Pneumoniae Infection Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 31. Global Klebsiella Pneumoniae Infection Drug Sales Market Share Geographic Region (2017-2022)

Table 32. Global Klebsiella Pneumoniae Infection Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Klebsiella Pneumoniae Infection Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 35. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Country/Region (2017-2022)

Table 36. Global Klebsiella Pneumoniae Infection Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022) & (K Pcs)

Table 39. Americas Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2017-2022)

Table 40. Americas Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2017-2022)

Table 42. Americas Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)

Table 43. Americas Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)

Table 44. Americas Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)

Table 45. Americas Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)

Table 46. APAC Klebsiella Pneumoniae Infection Drug Sales by Region (2017-2022) & (K Pcs)

Table 47. APAC Klebsiella Pneumoniae Infection Drug Sales Market Share by Region (2017-2022)

Table 48. APAC Klebsiella Pneumoniae Infection Drug Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Klebsiella Pneumoniae Infection Drug Revenue Market Share by Region (2017-2022)

Table 50. APAC Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)

Table 51. APAC Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)

Table 52. APAC Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)

Table 53. APAC Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)

Table 54. Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022) & (K Pcs)

Table 55. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2017-2022)

Table 56. Europe Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2017-2022)

Table 58. Europe Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)

Table 59. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)

Table 60. Europe Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)

Table 61. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)

Table 69. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Klebsiella Pneumoniae Infection Drug

Table 71. Key Market Challenges & Risks of Klebsiella Pneumoniae Infection Drug

Table 72. Key Industry Trends of Klebsiella Pneumoniae Infection Drug

Table 73. Klebsiella Pneumoniae Infection Drug Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Klebsiella Pneumoniae Infection Drug Distributors List

Table 76. Klebsiella Pneumoniae Infection Drug Customer List

Table 77. Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 78. Global Klebsiella Pneumoniae Infection Drug Sales Market Forecast by Region

Table 79. Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Klebsiella Pneumoniae Infection Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Americas Klebsiella Pneumoniae Infection Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Klebsiella Pneumoniae Infection Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 84. APAC Klebsiella Pneumoniae Infection Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Klebsiella Pneumoniae Infection Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Europe Klebsiella Pneumoniae Infection Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 88. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 90. Global Klebsiella Pneumoniae Infection Drug Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 94. Global Klebsiella Pneumoniae Infection Drug Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share Forecast by Application (2023-2028)

Table 97. Acies Bio doo Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 98. Acies Bio doo Klebsiella Pneumoniae Infection Drug Product Offered

Table 99. Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Acies Bio doo Main Business

Table 101. Acies Bio doo Latest Developments

Table 102. Appili Therapeutics Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 103. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product Offered

Table 104. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. Appili Therapeutics Main Business

Table 106. Appili Therapeutics Latest Developments

Table 107. Debiopharm International SA Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 108. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product Offered

Table 109. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Debiopharm International SA Main Business

Table 111. Debiopharm International SA Latest Developments

Table 112. Evaxion Biotech ApS Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 113. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product Offered

Table 114. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Evaxion Biotech ApS Main Business

Table 116. Evaxion Biotech ApS Latest Developments

Table 117. F. Hoffmann-La Roche Ltd Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 118. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product Offered

Table 119. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. F. Hoffmann-La Roche Ltd Main Business

Table 121. F. Hoffmann-La Roche Ltd Latest Developments

Table 122. FOB Synthesis Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 123. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product Offered

Table 124. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. FOB Synthesis Inc Main Business

Table 126. FOB Synthesis Inc Latest Developments

Table 127. ImmunoClin Corp Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 128. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product Offered

Table 129. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. ImmunoClin Corp Main Business

Table 131. ImmunoClin Corp Latest Developments

Table 132. Innovation Pharmaceuticals Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 133. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offered

Table 134. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. Innovation Pharmaceuticals Inc Main Business

Table 136. Innovation Pharmaceuticals Inc Latest Developments

Table 137. Kyorin Pharmaceutical Co Ltd Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 138. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product Offered

Table 139. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. Kyorin Pharmaceutical Co Ltd Main Business

Table 141. Kyorin Pharmaceutical Co Ltd Latest Developments

Table 142. Melinta Therapeutics Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 143. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offered

Table 144. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 145. Melinta Therapeutics Inc Main Business

Table 146. Melinta Therapeutics Inc Latest Developments

Table 147. Nosopharm SAS Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 148. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product Offered

Table 149. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 150. Nosopharm SAS Main Business

Table 151. Nosopharm SAS Latest Developments

Table 152. Peptilogics Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 153. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product Offered

Table 154. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 155. Peptilogics Inc Main Business

Table 156. Peptilogics Inc Latest Developments

Table 157. Pfizer Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 158. Pfizer Inc Klebsiella Pneumoniae Infection Drug Product Offered

Table 159. Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 160. Pfizer Inc Main Business

Table 161. Pfizer Inc Latest Developments

Table 162. Phico Therapeutics Ltd Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 163. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product Offered

Table 164. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 165. Phico Therapeutics Ltd Main Business

Table 166. Phico Therapeutics Ltd Latest Developments

Table 167. Sarepta Therapeutics Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 168. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offered

Table 169. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 170. Sarepta Therapeutics Inc Main Business

Table 171. Sarepta Therapeutics Inc Latest Developments

Table 172. Shionogi & Co Ltd Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 173. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product Offered

Table 174. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 175. Shionogi & Co Ltd Main Business

Table 176. Shionogi & Co Ltd Latest Developments

Table 177. Syntiron LLC Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 178. Syntiron LLC Klebsiella Pneumoniae Infection Drug Product Offered

Table 179. Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 180. Syntiron LLC Main Business

Table 181. Syntiron LLC Latest Developments

Table 182. Tetraphase Pharmaceuticals Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 183. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offered

Table 184. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 185. Tetraphase Pharmaceuticals Inc Main Business

Table 186. Tetraphase Pharmaceuticals Inc Latest Developments

List of Figures

Figure 1. Picture of Klebsiella Pneumoniae Infection Drug

Figure 2. Klebsiella Pneumoniae Infection Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Klebsiella Pneumoniae Infection Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Klebsiella Pneumoniae Infection Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Klebsiella Pneumoniae Infection Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of ATI-1503

Figure 10. Product Picture of CA-824

Figure 11. Product Picture of CC-1807

Figure 12. Product Picture of Cefiderocol

Figure 13. Product Picture of Debio-1454

Figure 14. Product Picture of EBX-004

Figure 15. Product Picture of Others

Figure 16. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type in 2021

Figure 17. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Type (2017-2022)

Figure 18. Klebsiella Pneumoniae Infection Drug Consumed in Hospital

Figure 19. Global Klebsiella Pneumoniae Infection Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 20. Klebsiella Pneumoniae Infection Drug Consumed in Clinic

Figure 21. Global Klebsiella Pneumoniae Infection Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 22. Klebsiella Pneumoniae Infection Drug Consumed in Others

Figure 23. Global Klebsiella Pneumoniae Infection Drug Market: Others (2017-2022) & (K Pcs)

Figure 24. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)

Figure 25. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Application in 2021

Figure 26. Klebsiella Pneumoniae Infection Drug Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company in 2021

Figure 28. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Geographic Region in 2021

Figure 30. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Region (2017-2022)

Figure 31. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country/Region in 2021

Figure 32. Americas Klebsiella Pneumoniae Infection Drug Sales 2017-2022 (K Pcs)

Figure 33. Americas Klebsiella Pneumoniae Infection Drug Revenue 2017-2022 ($ Millions)

Figure 34. APAC Klebsiella Pneumoniae Infection Drug Sales 2017-2022 (K Pcs)

Figure 35. APAC Klebsiella Pneumoniae Infection Drug Revenue 2017-2022 ($ Millions)

Figure 36. Europe Klebsiella Pneumoniae Infection Drug Sales 2017-2022 (K Pcs)

Figure 37. Europe Klebsiella Pneumoniae Infection Drug Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales 2017-2022 (K Pcs)

Figure 39. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue 2017-2022 ($ Millions)

Figure 40. Americas Klebsiella Pneumoniae Infection Drug Sales Market Share by Country in 2021

Figure 41. Americas Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country in 2021

Figure 42. United States Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Klebsiella Pneumoniae Infection Drug Sales Market Share by Region in 2021

Figure 47. APAC Klebsiella Pneumoniae Infection Drug Revenue Market Share by Regions in 2021

Figure 48. China Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Country in 2021

Figure 55. Europe Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country in 2021

Figure 56. Germany Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country in 2021

Figure 63. Egypt Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Klebsiella Pneumoniae Infection Drug in 2021

Figure 69. Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug

Figure 70. Industry Chain Structure of Klebsiella Pneumoniae Infection Drug

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles